Crinetics Pharmaceuticals, Inc.

CRNX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-014775
Filing date: Mar 4, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Okey Stephanie (Director)
SEC Filing link

Summary

Type

Sell

Net shares

-3,000

% of shares

-18.40%

Amount (USD)

$119,010

Insider confidence score

21.3 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Massive scheduled sell (<20% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-3,000.0

Price per Share

$39.67

Amount (USD)

$119,010.00

Acquired/Disposed

Disposed

Shares Owned Before

16,300.0

Shares Owned After

13,300.0

Filing's footnotes

1. The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.

2. The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $39.67 per share.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.